Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Board Meeting Intimation
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 and 50 of the Listing Regulations, we write to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, 08th November, 2022, inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September, 2022. In this regard, we write to inform you that the 'Trading Window' for dealing in the securities of the Company has been closed from Wednesday, 19th October, 2022 and will remain closed till Thursday, 10th November, 2022 (both days inclusive). Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for East Bridge Capital Master Fund Ltd & East Bridge Capital Master Fund I Ltd Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Caisse De Depot Et Placement Du Quebec Piramal Pharma Ltd - 543635 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay G Piramal & PACs Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ajay G Piramal & Others Piramal Pharma Ltd - 543635 - Listing of equity shares of Piramal Pharma Ltd
Trading Members of the Exchange are hereby informed that effective from October 19, 2022, the equity shares of Piramal Pharma Ltd (Scrip Code: 543635) are listed and admitted to dealings on the Exchange in the list of ''T'' Group Securities. For further details please refer to the notice no 20221017-16 dated October 17, 2022.